ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRDA Croda International Plc

4,655.00
36.00 (0.78%)
Last Updated: 09:43:43
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Croda International Plc LSE:CRDA London Ordinary Share GB00BJFFLV09 ORD 10.609756P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  36.00 0.78% 4,655.00 4,653.00 4,656.00 4,673.00 4,576.00 4,622.00 33,039 09:43:43
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Chemicals & Chem Preps, Nec 1.69B 171M 1.2246 37.94 6.49B
Croda International Plc is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker CRDA. The last closing price for Croda was 4,619p. Over the last year, Croda shares have traded in a share price range of 4,018.00p to 7,030.00p.

Croda currently has 139,635,400 shares in issue. The market capitalisation of Croda is £6.49 billion. Croda has a price to earnings ratio (PE ratio) of 37.94.

Croda Share Discussion Threads

Showing 576 to 600 of 700 messages
Chat Pages: 28  27  26  25  24  23  22  21  20  19  18  17  Older
DateSubjectAuthorDiscuss
22/11/2021
11:13
@rafboy

Since August 2020 Croda has completed four acquisitions:
Avanti Polar Lipids - US lipids
Iberchem - Fragrants
Alban Muller - Natural Ingredients
Parfex - Fragrants (purchase by Iberchem)

May 2021 it announced a "strategic review" of its Industrial Chemicals business.

A lot to speculate about for future performance and returns is my guess.

sogoesit
19/11/2021
14:00
Moving up but on what I wonder!
rafboy
12/11/2021
19:08
Croda are key to Nanoparticle supply for future rna vaccines not just Covid. OK it is only one of the products, but having just hit a 3 bagger for me today , I remain optimistic about the future here.
wad collector
23/9/2021
11:30
Beginning to think this, at 45x, may have more to go... 50x forward P/E for the current year?
Any takers?

Edit 28/09:
Or not!
Inflation, rising interest rates now kicking-in...

Edit 26/10:
or possibly yes...
;-))

Anyway, accumulated during the seasonal slump.

sogoesit
05/8/2021
11:50
Closing-in on my 45x forward earnings price target...
Will it, won't it?

EDIT:
Yep, 45 x 1.1 x 2 = 90 (give or take a fiver).

GLA

sogoesit
05/8/2021
09:51
Croda International PLC - Yorkshire, England-based chemicals maker - Non-Executive Director Keith Layden and Julie Layden sell 19,975 shares in total at GBP86.10, worth GBP1.7 million, on Wednesday,4th Aug.
steeplejack
30/7/2021
15:28
Indeed, let’s hope it grows back into its historic 45x p/e for us holders left behind…
sogoesit
28/7/2021
08:36
smart move uncle sam as profit takers move in !
arja
27/7/2021
13:01
yes , but prospective p/e figure will still be quite high and CRDA would be hit if anything went a bit wrong . But share price keeps shooting up and how long is a piece of string !
arja
27/7/2021
12:57
“….. profit…. significantly ahead of current expectations.”
Those woz the key words!

sogoesit
27/7/2021
12:36
but a real NOR situation and not sure it is smart to exit unless you trade the stock of course . Maybe sell half under BHR policy but you follow the stock more than I do and US indices may tank at any time .
arja
27/7/2021
08:55
Excellent results. Astounding share price. But while their business model is positive global macro predictions are less so. Am taking profits here.
uncle_sam
27/7/2021
07:48
From today’s HY Results:

“Outlook
The first half year has seen a strong performance across the Group, reflecting the global recovery in demand, the accelerated implementation of our strategic priorities and increased investment.

We expect underlying growth across all sectors to continue in the second half year, driven by consumer demand, whilst the customer restocking seen in the first half is expected to moderate. Together with the benefit of recent acquisitions opening up new fast growth markets, we expect continued strong demand for lipid systems and are increasing guidance for sales this year to at least US$200m.

We now expect 2021 full year adjusted profit before tax to be significantly ahead of current expectations. Subject to there being no material change in current market conditions, we expect a similar phasing of profit between the first and second half periods as seen in previous years.

Demand for COVID-19 solution ingredients remains uncertain beyond the short term and the current level of sales could moderate; however, we expect to see an ongoing expansion in the range of applications for lipid systems in vaccines and therapeutic drugs over the medium term. Across the wider Group, the combination of our differentiated business model, healthy innovation pipeline and recent investment is expected to underpin performance and continue to generate increased value for all our stakeholders.”

sogoesit
14/12/2020
01:54
Just to mention that the Xmas MelloMonday special guest may mention Croda and I think shareholders and potential investors will appreciate his thoughts. There is an interview tonight with Keith Ashworth Lord who is a highly respected fund manager and well worth listening to. Keith's fund Castlefield are of course one of the larger shareholders in Croda and I think it is one of their top ten positions.

The Mello Monday event starts at 6pm
The full programme is available on the website.

Also of interest may be the MelloBASH... The analysts, fund manager and well known investors on the panel will give their honest verdicts on whether four companies are a Buy Avoid Sell or Hold at this current juncture in the markets.



All investors welcome and if you use the code MMTADVFN50 you will get a half price ticket. Great investor content and entertainment. We had nearly 400 investors attend last month so these are very popular.

davidosh
13/11/2020
08:08
Market does not appear to like the Sky News story - its still going down.
Anyone know why?

I would have thought winning the covid19 contract from Phizer has to be good news as one would expect the other vaccines will also have to buy from Croda (they probably are all very similar).

netcurtains
12/11/2020
18:00
Yep that’s what the runs said on the 10th with the £100 mil deal, surprised by the lack of interest
nerja
12/11/2020
16:04
Sky news???
Croda working with Phizer, that is good news!!!

lysandrospanayi
10/11/2020
13:51
Get in there!
nerja
16/9/2020
17:05
‘Vaccine adjuvant hopes perhaps?’

Could be. Looking really expensive now!

frazboy
27/7/2020
17:27
Vaccine adjuvant hopes perhaps?
dab26
27/7/2020
17:24
I'm not sure tbh.....would love to be able to call the top of this one as think it has a long way to fall, even considering their latest investment. Is it a solid company?....yes. Do current results justify a breakout...not imo. I'm not sure their outlook is too rosy either as not all their segments are doing well in a Covid world.
lyndon b
27/7/2020
15:51
Could also be a short squeeze? There was approaching 5% stock on loan prior to results. I wouldn't have thought the results were good enough to make the shorters run for the hills but they were perhaps better than expected. Marshall Wace has, for example, been short from much lower down.
frazboy
27/7/2020
14:50
I think the only explanation is the dividend (and it being maintained, while most other companies have not held it in place). Big investors are holding for that reason and getting a capital gain to boot.If you look at the financials of this company on their own (profit down 10%), some margin erosion in their high end personal care segment, some business segment links to automotive/oil industry etc etc, then the share price gain/ALL TIME HIGH makes zero sense.Based on current/future trading against historical, then £50/share makes better sense, though as we all know SP's rarely make sense.
lyndon b
27/7/2020
13:34
it's a good question arja... it's clearly a benefactor of having some growth (in particular, in the life science area), and being resolute. Perhaps the greatest driver of the price of late is long term bond yields falling - discounting of future earnings at a lower rate helps drive valuations. can't see it rising much further, and, in fact, I'm looking for a short opportunity, but i'm not fighting the current trend.
frazboy
27/7/2020
10:22
what is so special about this stock as , even on a bearish day, it keeps hitting new al time highs . ? tempting to buy but maybe too risky after such a run !
arja
Chat Pages: 28  27  26  25  24  23  22  21  20  19  18  17  Older

Your Recent History

Delayed Upgrade Clock